The company has significantly boosted the development of the new solution for ATTR-CM, employing the investigational drug. Initial patient results suggests potential benefits for those suffering from the serious https://bridgebio700125.tblogz.com/company-progresses-amyloidosis-treatment-using-the-drug-55332866